Micro-X Ltd.
0.06
AUD
0.00
(0.00%)
ISIN
AU000000MX15
Return %
Stock
S&P 500
1Y
-44.76
14.20
3Y
-53.16
81.12
5Y
-81.70
68.34
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.Company Description
- CEO
- Kingsley Campbell Hall
- Full Time Employees
- 7,935
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- A14, 6 MAB Eastern Promenade Tonsley SA Australia 5042
- IPO Date
- Dec 22, 2015
- Website
- micro-x.com
- Similar Companies
- Business
- Micro-X Limited designs, develops, manufactures, and commercializes advanced imaging products for healthcare, defense, and security markets, leveraging its proprietary cold cathode carbon nanotube (CNT) X-ray technology. The company’s core products include the Rover Plus mobile digital X-ray system; Head CT scanners aimed at stroke diagnostics in ambulances; full-body portable CT scanners developed under the ARPA-H funded PARADIGM program; the Argus and Checkpoints security imaging devices; and custom imaging solutions tailored to specific client needs. Micro-X operates primarily in the United States, Australia, Asia-Pacific, and parts of Europe, with headquarters in Melbourne, Australia, and was founded in 2006. In the last two years, Micro-X has undergone a strategic refocus to prioritize medical imaging, particularly mobile and portable X-ray and CT systems, discontinuing the Argus security operations to reduce costs and concentrate resources. The company secured a AU$5.6 million strategic partnership with Billion Prima for scanner commercialization in February 2025, facilitating cash flow stability and broader market access. Micro-X launched a $6.0 million capital raising in early 2025 to fund its business transition towards medical imaging products and build commercial partnerships. It also entered a long-term alliance with Thales Group to jointly market its mobile backscatter imaging technology for security applications. Most recently, Micro-X unveiled an upgraded Rover mobile X-ray system at RSNA 2025, featuring a next-generation high-resolution Lumen glass-free detector, in-bin charging for improved usability, and a redesigned user interface, reinforcing its position in point-of-care digital radiography. Additionally, the company's Head CT scanner for stroke and full-body portable CT concepts remain in development, targeting emergency and remote healthcare markets. Micro-X Limited operates within the healthcare equipment and advanced medical imaging segments, targeting hospital, emergency medical, security, and defense customers globally. The company’s product innovation focuses on ultra-lightweight, motor-free designs that enhance portability and operational efficiency in clinical and field environments. Its strategic realignment and new funding emphasize commercial execution and growth in medical imaging, leveraging its unique CNT X-ray technology platform.